SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-034916
Filing Date
2024-11-13
Accepted
2024-11-13 16:18:34
Documents
78
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q zvra20240930_10q.htm   iXBRL 10-Q 1619134
2 EXHIBIT 31.1 ex_716263.htm EX-31.1 13783
3 EXHIBIT 31.2 ex_716264.htm EX-31.2 13973
4 EXHIBIT 32.1 ex_716265.htm EX-32.1 7069
5 EXHIBIT 32.2 ex_716266.htm EX-32.2 7338
  Complete submission text file 0001437749-24-034916.txt   8085499

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA zvra-20240930.xsd EX-101.SCH 74268
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zvra-20240930_cal.xml EX-101.CAL 70611
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zvra-20240930_def.xml EX-101.DEF 486539
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE zvra-20240930_lab.xml EX-101.LAB 453937
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zvra-20240930_pre.xml EX-101.PRE 521736
81 EXTRACTED XBRL INSTANCE DOCUMENT zvra20240930_10q_htm.xml XML 1242153
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36913 | Film No.: 241454558
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)